Orrstown Financial Services’s AbbVie ABBV Stock Holding History

Orrstown Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$895K	Buy	3,558 +972	+38%	+$209K	0.13%	65
2026 Q1	$562K	Sell	2,586 -60	-2%	-$13.3K	0.09%	85
2025 Q4	$605K	Hold	2,646	–	–	0.1%	93
2025 Q3	$613K	Sell	2,646 -854	-24%	-$174K	0.1%	86
2025 Q2	$650K	Sell	3,500 -241	-6%	-$44.8K	0.14%	80
2025 Q1	$784K	Sell	3,741 -1,171	-24%	-$228K	0.19%	65
2024 Q4	$873K	Sell	4,912 -210	-4%	-$38.6K	0.23%	62
2024 Q3	$1.01M	Buy	+5,122	New	+$956K	0.3%	60
2019 Q4	–	Sell	-303	Closed	-$20K	–	88
2019 Q3	$20K	Hold	303	–	–	0.03%	166
2019 Q2	$22K	Buy	+303	New	+$23.8K	0.03%	155
2019 Q1	–	Sell	-260	Closed	-$24K	–	223
2018 Q4	$24K	Buy	+260	New	+$22.9K	0.04%	139
2018 Q3	–	Sell	-1,055	Closed	-$98K	–	218
2018 Q2	$98K	Hold	1,055	–	–	0.12%	107
2018 Q1	$100K	Sell	1,055 -50	-5%	-$5.49K	0.12%	111
2017 Q4	$107K	Hold	1,105	–	–	0.12%	108
2017 Q3	$98K	Sell	1,105 -175	-14%	-$13.3K	0.11%	112
2017 Q2	$93K	Buy	1,280 +175	+16%	+$11.8K	0.1%	116
2017 Q1	$72K	Buy	+1,105	New	+$69.5K	0.07%	132
2015 Q4	–	Sell	-200	Closed	-$11K	–	216
2015 Q3	$11K	Hold	200	–	–	0.01%	152
2015 Q2	$13K	Buy	+200	New	+$13.1K	0.01%	152

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Orrstown Financial Services's ABBV Position: Q2 2026 in Review

Orrstown Financial Services increased its AbbVie (ABBV) stake by 38% in Q2 2026, buying an estimated $209K and bringing the position to 3,558 shares worth $895K. The position accounts for 0.13% of the portfolio, ranked #65.

Orrstown Financial Services first reported a position in ABBV in Q2 2015 and has held it in 19 quarters since. The position peaked at $1.01M in Q3 2024. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Orrstown Financial Services held 3,558 shares of AbbVie worth $895K as of Q2 2026.
Orrstown Financial Services bought 972 AbbVie shares in Q2 2026, an estimated $209K.
AbbVie made up 0.13% of Orrstown Financial Services's portfolio in Q2 2026, its #65 holding.
Orrstown Financial Services first reported a position in AbbVie in Q2 2015 and has held it in 19 quarters since.
Orrstown Financial Services's AbbVie position peaked at $1.01M in Q3 2024.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Orrstown Financial Services's 13F filing for Q2 2026, filed 10 Jul 2026.